Top Growth Trends in the Immuno-Oncology Drugs Market: Insights into Market Size and Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theImmuno-Oncology Drugs Market?
The global upsurge in cancer cases is predicted to augment the growth of the immuno-oncology drugs market. For example, data from the American Cancer Society in January 2022 projects about 1.9 million fresh cancer diagnoses and 609,360 cancer-related deaths in the US alone, making it about 1,670 deaths daily. The four most prevalent cancers globally include those of the lung, prostate, bowel, and breast in women, making up 43% of all new cases of cancer. Such figures suggest a rise in the global incidence of cancer, likely to accelerate the demand for immuno-oncology drugs in the forthcoming years.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3455&type=smp
How Will the Growth Rate of theImmuno-Oncology Drugs Market Impact Industry Trends by 2034?
In recent times, there’s been a swift expansion in the size of the immuno-oncology drugs market. Projected to surge from $94.16 billion in 2024 to $106.92 billion in 2025, it boasts a compound annual growth rate (CAGR) of 13.6%. Factors that contributed to this growth in the historical period include a surge in cancer incidents, robust economic progress in emerging markets, escalated expenditure on healthcare, and a rise in spendings on R&D in the pharmaceutical sector.
The market size for immuno-oncology drugs is anticipated to experience significant expansion in the coming years. By 2029, it’s expected to reach a value of $153.16 billion, with an annual compound growth rate (CAGR) of 9.4%. This surge in growth during the forecast period can be linked to an escalated investment in immuno-oncology, increased attention towards immunotherapy drugs for cancer treatment, and product breakthroughs. Key trends to watch out for during this forecast period include the development of customized oncology drugs tailored to individual patients, a concentrated effort towards next-generation biologics, the creation of antibody-drug conjugates, investment in AI solutions to cut down on R&D expenses and speed up the development process, combination therapies in immuno-oncology to drive innovation and establish dominance in the category, as well as the usage of CAR-T therapies to spurn innovation and secure leadership in the category.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3455
What Are the Current Market Growth and Trends in theImmuno-Oncology Drugs Market That Industry Players Should Watch?
In the immuno-oncology drugs market, leading firms are joining forces to create and bring to market a new checkpoint antibody to improve the efficacy of cancer therapies. Such strategic partnerships encourage innovation by facilitating the exchange of ideas across different fields, accelerating the development of combination therapies, customized treatments, and innovative drug delivery systems. For example, in March 2023, Germany’s BioNTech SE formed a collaboration with US-based OncoC4 Inc to jointly create and sell a checkpoint antibody, particularly the anti-CTLA-4 monoclonal antibody candidate referred to as ONC-392. This alliance is looking to improve cancer therapy alternatives for various solid tumor conditions.
What Are the Major Market Players Making an Impact on theImmuno-Oncology Drugs Market Growth?
Major companies operating in the immuno-oncology drugs market include F. Hoffmann-La Roche Ltd., Merck & Co., Bristol-Myers Squibb Company, Amgen Inc, Johnson & Johnson, AstraZeneca Plc, Eli Lilly and Company, Novartis International AG, Pfizer Inc., Sanofi S.A., Arlak Biotech, Apikos Pharma, Kolaz biotech, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Takeda Pharmaceuticals, Astellas Pharma Inc, Otsuka Pharmaceutical Co, Ltd, Legend Biotech Co, Zai Lab, Daiichi Pharmaceutical and Sankyo, AQVIDA GmbH, Baxter International Inc., GlaxoSmithKline plc, Affimed Therapeutics, Autolus Therapeutics, Cellectis, Celyad, GammaDelta Therapeutics, Immunocore, European Medical Center (EMC), Yauza Medical Center, Celon Pharma, Veropharm, Biocad, Selvita, OncoArendi Therapeutics Mabion, Fate Therapeutics, Forty-Seven, Arcus Biosciences, Gritstone Oncology, Rakuten Medical, Rubius Therapeutics, Allogene Therapeutics, Celgene Corporation, Bayer AG, Incyte Corporation, Recepta Biopharma, CSC Pharmaceuticals International, Blanver EN, Sandoz Brazil, Life Pharma, Julphar, NewBridge Pharmaceuticals, Eurolab
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report
How Are the Key Segments of the Immuno-Oncology Drugs Market Driving Opportunities and Innovations?
The immuno-oncology drugs market covered in this report is segmented –
1) By Type: Immune Checkpoint Inhibitors, Immune System Modulators, Other Monoclonal Antibodies, Cancer Vaccines, Others
2) By Therapeutic Application: Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Bladder Cancer, Other Therapeutic Application
3) By End-Users: Hospitals, Clinics, Ambulatory Surgical Centers, Others
Subsegments:
1) By Immune Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors
2) By Immune System Modulators: Cytokines, Interferons, Colony-Stimulating Factors
3) By Other Monoclonal Antibodies: Targeted Monoclonal Antibodies, Bispecific Antibodies
4) By Cancer Vaccines: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines
5) By Others: Adoptive Cell Transfer Therapies, Oncolytic Virus Therapies
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=3455&type=smp
What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theImmuno-Oncology Drugs Market?# Market Expansion?
North America was the largest region in the immuno-oncology drugs market in 2024. The regions covered in the immuno-oncology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Global Immuno-Oncology Drugs Market 2025, By The Business Research Company:
Dental Equipment And Supplies Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/dental-equipment-and-supplies-global-market-report
Magnetic Resonance Imaging Devices And Equipment Global Market Report 2019
Electrophysiology Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
